EP2931752
Meðhöndlun CD47+ sjúkdómsfrumna með SIRP ALFA-FC samrunaprótínum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.12.2013EP published:
14.8.2019EP application number:
13865442.1
EP translation filed:
12.11.2019Grant published:
15.12.2019EPO information:
European Patent Register
Max expiry date:
16.12.2033Expiry date:
16.12.2026Next due date:
31.12.2026
Title:
TREATMENT OF CD47+ DISEASE CELLS WITH SIRP ALPHA-FC FUSIONS
Timeline
Today
17.12.2013EP application
14.8.2019EP Publication
12.11.2019Translation submitted
15.12.2019Registration published
16.12.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
UGER, Robert AdamAddress:
Richmond Hill, ON L4C 7S4, CA
Name:
SLAVOVA-PETROVA, Penka SlavtchevaAddress:
Toronto, ON M8V 3X1, CA
Name:
PANG, XinliAddress:
Brampton, ON L6R 3H1, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261738008 PDate:
17.12.2012Country:
US
Classification
Categories:
C07K 19/00, A61K 38/16, A61K 38/45, A61P 35/02, C07K 14/705, C07K 16/00, C12N 15/62, A61K 38/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 20.12.2019
Expires: 16.12.2020
Payer: Tego ehf.
Number: 8
Paid: 15.12.2020
Expires: 16.12.2021
Payer: Árnason Faktor ehf.
Number: 9
Paid: 6.12.2021
Expires: 16.12.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.11.2022
Expires: 16.12.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 15.11.2023
Expires: 16.12.2024
Payer: Árnason Faktor ehf.
Number: 12
Paid: 11.11.2024
Expires: 16.12.2025
Payer: Árnason Faktor ehf.
Number: 13
Paid: 9.12.2025
Expires: 16.12.2026
Payer: Árnason Faktor ehf.